Orchestra BioMed Holdings, Inc.
live · Yahoo FinanceLimited buying: $6.2M bought (counted up to $5.0M); 5 distinct insiders. Holding it back: largest buyer: Taylor Andrew Lawrence (CFO), 96% of the dollars.
AI summary Insiders and ten percent owner buy shares in public offering
Score, not a recommendation.
same price, one day All 5 purchases were at $5.00 on 2026-11-09. That pattern also occurs in IPO or conversion subscriptions, which are not open-market conviction buying.
Price and insider purchases
Live chart from Yahoo Finance, loaded through this server; our daily closes when it is unavailable.
Loading price history…
How the score adds up
How each input is counted →| Input | Strength | Points |
|---|---|---|
| $6.2M bought (counted up to $5.0M)The dollars the insiders bought, a purchase reported jointly counted once, counted from $131. Each tenfold adds 12.4 points, up to $5.0M; more adds nothing. The bar is empty at $10.0K and full at $5.0M. | 100% | +57 |
| 5 distinct insidersHow many different insiders bought. Each extra insider adds less than the one before (the points follow the log of the count: 4.3 per doubling). The bar is full at 10 insiders. | 70% | +10 |
| No CEO among the buyersWhether the chief executive is among the buyers: 10.6 points when yes. | 0% | +0 |
| Stock 11% below its 1-year highHow far the stock had fallen from its highest close of the past year, at the close before the buying. Every 10% of fall adds 1.9 points. A fall beyond 30% adds nothing more. The bar is full at a 30% fall. | 35% | +2 |
| 0 days from first to last purchaseDays between the first and the last purchase. Each day takes off 0.11 points: buying close together keeps more. The bar is empty at 60 days. | 100% | +0 |
| Routine or plan purchases: 0% of the dollars | 100% | +0 |
| Largest buyer: Taylor Andrew Lawrence (CFO), 96% of the dollars | 5% | -12 |
| Match scoreA score from 0 to 100 worked out from the dollars bought, the number of insiders, whether a CEO bought, how far the stock had fallen, how spread out the purchases were and how much came from one buyer. Its weights were calibrated on past clusters. It is the default ranking of the lists and it decides which clusters get the AI review. It describes the buying; it is not a forecast. | 57 | |
| AI adjustmentPoints added or taken off by a language model that reads the SEC filings and recent news about the cluster and classifies the buying (for example open market, plan or offering). It can be wrong, it is shown as its own line, and it is never used in past results. | -14 | |
| Insider ScoreThe number from 0 to 100 shown on each cluster and used to rank the lists. By default it is the match score, plus the points of the AI review when there is one. It describes the buying; it is not a forecast or a recommendation. | 43 | |
Why are they buying?
AI · ipo_offering · catalyst none · documentedInsiders and major shareholders purchased shares directly as part of the company's underwritten public offering rather than through open-market transactions.
Orchestra BioMed priced its underwritten public offering of 15,000,000 common shares at $5.00 per share, raising capital to fund its clinical trials and general corporate purposes.
| Date | InsiderAn officer or director of a company, or an owner of more than 10% of its shares. The law requires them to report their trades in the company's stock to the SEC. | Role | Shares | Price | Value | Flags | Filing |
|---|---|---|---|---|---|---|---|
| 2026-11-09 | RTW INVESTMENTS, LP 4 purchases with a 63-day result · median -0.8% | 10% owner | 1,200,000 | $5.00 | $6.0M | SEC filing for RTW INVESTMENTS, LP (opens in a new tab) | |
| 2026-11-09 | Pacitti David history of Pacitti David's purchases | Director | 20,000 | $5.00 | $100.0K | SEC filing for Pacitti David (opens in a new tab) | |
| 2026-11-09 | Fain Eric S history of Fain Eric S's purchases | Director | 20,000 | $5.00 | $100.0K | SEC filing for Fain Eric S (opens in a new tab) | |
| 2026-11-09 | Hochman David P 11 purchases with a 63-day result · median -3.5% | Director | 5,000 | $5.00 | $25.0K | SEC filing for Hochman David P (opens in a new tab) | |
| 2026-11-09 | Taylor Andrew Lawrence history of Taylor Andrew Lawrence's purchases | CFO | 1,000 | $5.00 | $5.0K | SEC filing for Taylor Andrew Lawrence (opens in a new tab) | |
| Total | $6.2M | ||||||
Other buying runs at OBIO
A buying runPurchases at one company with no pause longer than the cluster rule allows. A long pause ends the run, so one company can have several. ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmarkThe index a stock's return is compared with: a small-cap index for small companies, a large-cap index otherwise. (IWM for small companies, SPY otherwise), from the first open after the buying run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2026-05-14 → 2026-06-01 | 3 | $158.1K | 46 | -8.0% (+0.3% raw) | +29.0% (+39.4% raw) | – | closed |
| 2025-08-01 → 2025-09-19 | 6 | $2.0M | 37 | -11.7% (-8.6% raw) | +78.6% (+82.0% raw) | +47.8% (+62.8% raw) | closed |
| 2020-08-04 → 2020-08-06 | 3 | $4.8M | 37 | -6.3% (-4.9% raw) | -12.8% (-7.9% raw) | -7.4% (+10.1% raw) | closed |